Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers.

BSP090--the follow-up to CREATE.

Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy.

IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias.

Paternally inherited case of congenital DM1: brain MRI and review of literature.

The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway.

Synthesis of new pyrazolo[5,1-c][1,2,4] benzotriazines, pyrazolo[5,1-c]pyrido[4,3-e][1,2,4] triazines and their open analogues as cytotoxic agents in normoxic and hypoxic conditions.

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways.

[Ashy dermatosis: clinico-pathological associations in two cases].

Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent.